What are the contraindications to the annual influenza vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Contraindications to Annual Influenza Vaccine

The absolute contraindications to influenza vaccination are history of severe allergic reaction (anaphylaxis) to any component of the specific vaccine being considered, and for LAIV (live attenuated nasal spray), additional contraindications include immunocompromised states, pregnancy, aspirin therapy in children/adolescents, and specific respiratory conditions. 1

Contraindications by Vaccine Type

All Influenza Vaccines (IIV, RIV, LAIV)

  • Severe allergic reaction (anaphylaxis) to any component of that specific vaccine formulation 1
  • Severe allergic reaction to a previous dose of any influenza vaccine (with vaccine-specific considerations detailed below) 1

Important clarification on egg allergy: Despite being a labeled contraindication for egg-based vaccines, ACIP explicitly recommends that persons with egg allergy of any severity CAN receive any influenza vaccine (egg-based or non-egg-based) appropriate for their age and health status. This represents a critical divergence between package labeling and clinical practice guidelines. 1

Live Attenuated Influenza Vaccine (LAIV/Nasal Spray) - Additional Contraindications

Beyond the universal contraindications, LAIV has multiple additional absolute contraindications 1:

  • Concomitant aspirin or salicylate-containing therapy in children and adolescents
  • Children aged 2-4 years with asthma or wheezing history (diagnosis of asthma, parental report of wheezing/asthma in preceding 12 months, or documented wheezing episode in medical record)
  • Immunocompromised persons due to any cause (medications, HIV infection, etc.)
  • Close contacts/caregivers of severely immunosuppressed persons requiring protected environments
  • Pregnancy
  • Receipt of influenza antiviral medication within previous 48 hours (for 2018-19 season) 2

Cross-Reactivity Considerations for Previous Vaccine Reactions

If a patient had anaphylaxis to a previous influenza vaccine, the 2024-25 ACIP guidelines provide specific cross-contraindication patterns 1:

  • Previous reaction to egg-based IIV or LAIV: Contraindicated from all future egg-based vaccines; can use ccIIV or RIV as precaution (with medical supervision)
  • Previous reaction to ccIIV: Contraindicated from future ccIIV; can use RIV as precaution (with medical supervision)
  • Previous reaction to RIV: Contraindicated from future RIV; can use ccIIV as precaution (with medical supervision)

Precautions (Not Absolute Contraindications)

These conditions warrant deferral but are NOT absolute contraindications 1:

  • Moderate or severe acute illness with or without fever (defer until recovery)
  • History of Guillain-Barré syndrome within 6 weeks of previous influenza vaccination
  • For LAIV specifically: Asthma in persons ≥5 years, chronic medical conditions predisposing to influenza complications (pulmonary, cardiovascular except isolated hypertension, renal, hepatic, neurologic, hematologic, metabolic disorders including diabetes)

Critical Clinical Pitfalls

  1. Do not withhold vaccination for egg allergy: This is the most common error. Even patients with severe egg allergy requiring epinephrine can receive influenza vaccine. Those with reactions beyond urticaria should be vaccinated in a medical setting with supervision, but vaccination should proceed. 1, 3

  2. Distinguish contraindications from precautions: Guillain-Barré syndrome history and moderate illness are precautions requiring clinical judgment, not absolute contraindications.

  3. LAIV has substantially more contraindications than injectable vaccines: When in doubt with high-risk patients, use IIV or RIV rather than LAIV.

  4. Component-specific reactions matter: If anaphylaxis occurred to a previous vaccine, identify which type (egg-based, cell-culture-based, or recombinant) to select an alternative formulation rather than avoiding all influenza vaccines.

References

Related Questions

A patient received a flu vaccine on Tuesday and three days later (Friday) still has persistent redness at the injection site; what, if any, intervention is required?
Does the influenza vaccine administered in Australia provide protection against strains circulating in the United States?
What are the absolute indications for influenza vaccination?
How should a 2-year-old with negative COVID-19 and influenza rapid tests and a 10-day history of fever, wet cough, and nasal congestion be evaluated and managed?
In a 30-year-old woman recovering from influenza A infection who developed acute symmetric ascending weakness and tingling of the lower extremities over the past 12 hours with normal vital signs and symmetrical foot paralysis, what is the most likely diagnosis?
What is the appropriate medication regimen for a 25‑week‑gestation pregnant woman presenting with an allergy?
Can a urinary catheter be removed after initiating tamsulosin therapy?
Are all adult patients with neuroblastoma classified as high‑risk?
What is the recommended management for a 10-year-old with a radial shaft stress fracture, bone‑marrow edema, and radial nerve neurapraxia causing persistent pain?
In a 61‑year‑old woman with a lipoprotein(a) level of 216 nmol/L, can this value alone reclassify her into the very‑high cardiovascular risk category?
What is the recommended asthma management protocol for an adult patient in Australia for a GP, including diagnosis confirmation, initial low‑dose inhaled corticosteroid (ICS) therapy, step‑up to a combination inhaler with long‑acting β2‑agonist (LABA), a personalized asthma action plan, and treatment of acute exacerbations?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.